Subtype
Muscle Neoplasm
CI-CAN-00001246Explore in graph →
Non-malignant151 active trials1 approved drugs38 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001246Explore in graph →
Clinical trials
760 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00131365 | Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids | completed | N/A | 9 | InSightecINDUSTRY | 1 | Jun 12, 2019 | clinicaltrials |
| NCT02147158 | A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas | completed | Phase 3 | 432 | AllerganINDUSTRY | 2 | Jun 4, 2019 | clinicaltrials |
| NCT03773510 |
| Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin(TRADITIONS) |
| withdrawn |
| Phase 3 |
| 0 |
| Italian Sarcoma GroupNETWORK |
| 1 |
| May 13, 2019 |
| clinicaltrials |
| NCT03880045 | Topical Tranexamic Acid Plus Perivascular Vasopressin at the Time of Abdominal Myomectomy | unknown | N/A | 100 | Aswan University HospitalOTHER | 1 | May 13, 2019 | clinicaltrials |
| NCT03880604 | Triple Tourniquets With or Without Tranexamic Acid for Reducing Blood Loss at Open Myomectomy(TTT) | unknown | N/A | 100 | Aswan University HospitalOTHER | 1 | May 13, 2019 | clinicaltrials |
| NCT03072446 | Uterine Fibroid Embolization (UFE) for Symptomatic Fibroids: Comparison of Gel-Bead to Commonly Used Embolic Agents. | completed | N/A | 11 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | May 9, 2019 | clinicaltrials |
| NCT03937401 | Oxytocin in MRI-HIFU | unknown | Phase 4 | 100 | Turku University HospitalOTHER_GOV | 1 | May 3, 2019 | clinicaltrials |
| NCT02147197 | A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas | completed | Phase 3 | 157 | AllerganINDUSTRY | 1 | Apr 30, 2019 | clinicaltrials |
| NCT02914704 | Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) | unknown | N/A | 500 | Turku University HospitalOTHER_GOV | 1 | Apr 29, 2019 | clinicaltrials |
| NCT02409576 | Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas(NKEXPSARC) | unknown | Phase 1 / Phase 2 | 20 | National University Hospital, SingaporeOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03904368 | The Value of Myomectomy in Women With Intramural Myoma Before IVF. | unknown | N/A | 100 | Cairo UniversityOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT02747550 | Temporary Simultaneous Two-arterial Occlusions During Laparoscopic Myomectomy(TESTO) | completed | N/A | 80 | Kangbuk Samsung HospitalOTHER | 1 | Apr 2, 2019 | clinicaltrials |
| NCT02655224 | A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids | completed | Phase 3 | 65 | TakedaINDUSTRY | 1 | Mar 22, 2019 | clinicaltrials |
| NCT02655237 | A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids | completed | Phase 3 | 281 | TakedaINDUSTRY | 1 | Mar 22, 2019 | clinicaltrials |
| NCT01142791 | Safety Study of ExAblate for the Treatment of Uterine Fibroids | completed | N/A | 121 | InSightecINDUSTRY | 1 | Mar 19, 2019 | clinicaltrials |
| NCT02557854 | HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors | withdrawn | Phase 1 | 0 | Theodore LaetschOTHER | 1 | Mar 19, 2019 | clinicaltrials |
| NCT03437070 | Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma | withdrawn | Phase 1 | 0 | University of MiamiOTHER | 0 | Mar 18, 2019 | clinicaltrials |
| NCT01285960 | ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids | completed | N/A | 108 | InSightecINDUSTRY | 1 | Mar 6, 2019 | clinicaltrials |
| NCT02879058 | Intraoperative Ultrasound in Laparoscopic or Robotic Myomectomy Patients | terminated | N/A | 140 | The Cleveland ClinicOTHER | 1 | Mar 4, 2019 | clinicaltrials |
| NCT03792009 | Paracervical Block in Laparoscopic Hysterectomy(PALAPA) | unknown | N/A | 86 | Kangbuk Samsung HospitalOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT03847077 | Trial of a Patient Education Tool For Leiomyoma(PETAL) | completed | N/A | 72 | Loyola UniversityOTHER | 0 | Feb 20, 2019 | clinicaltrials |
| NCT00365989 | MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication | completed | Phase 3 | 50 | InSightecINDUSTRY | 2 | Feb 5, 2019 | clinicaltrials |
| NCT02303262 | SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma | completed | Phase 2 | 20 | Sarcoma Alliance for Research through CollaborationOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT03349190 | Impact of Esmya on Fertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques(NACRE) | completed | — | 127 | ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITROOTHER | 2 | Jan 9, 2019 | clinicaltrials |
| NCT03784976 | Iyengar Yoga Therapy for Dysmenorrhea and Endometriosis | unknown | N/A | 90 | University of Illinois at Urbana-ChampaignOTHER | 1 | Dec 24, 2018 | clinicaltrials |
| NCT00295217 | MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation | completed | Phase 3 | 15 | InSightecINDUSTRY | 1 | Dec 20, 2018 | clinicaltrials |
| NCT01614795 | Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma | completed | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 2 | Dec 11, 2018 | clinicaltrials |
| NCT00464620 | Trial of Dasatinib in Advanced Sarcomas | completed | Phase 2 | 366 | Sarcoma Alliance for Research through CollaborationOTHER | 1 | Nov 23, 2018 | clinicaltrials |
| NCT00414076 | Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma | terminated | Phase 2 | 9 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 20, 2018 | clinicaltrials |
| NCT01750008 | Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions(LUSTOR) | completed | N/A | 51 | Acessa Health, Inc.INDUSTRY | 1 | Nov 20, 2018 | clinicaltrials |
| NCT02942537 | Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment(MYOMIC1) | unknown | Phase 2 / Phase 3 | 36 | Karolinska InstitutetOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT02472184 | Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy | completed | N/A | 78 | University of South FloridaOTHER | 1 | Sep 26, 2018 | clinicaltrials |
| NCT01807468 | Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors | unknown | Phase 2 | 12 | Samsung Medical CenterOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT00070109 | Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors | completed | Phase 2 | 50 | Children's Oncology GroupNETWORK | 2 | Sep 14, 2018 | clinicaltrials |
| NCT03586947 | Association Between Vitamin D and the Risk of Uterine Fibroids(ABVDATROUF) | unknown | N/A | 1,160 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Sep 5, 2018 | clinicaltrials |
| NCT00730886 | ExAblate Treatment of Uterine Fibroids for Fertility Enhancement | terminated | N/A | 2 | InSightecINDUSTRY | 1 | Aug 15, 2018 | clinicaltrials |
| NCT01154452 | Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma | completed | Phase 1 / Phase 2 | 78 | National Cancer Institute (NCI)NIH | 1 | Aug 15, 2018 | clinicaltrials |
| NCT02011126 | Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors | withdrawn | Phase 2 | 0 | Children's Oncology GroupNETWORK | 0 | Aug 7, 2018 | clinicaltrials |
| NCT03111069 | Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 20, 2018 | clinicaltrials |
| NCT00668148 | A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma | completed | Phase 2 | 113 | Eli Lilly and CompanyINDUSTRY | 7 | Jul 17, 2018 | clinicaltrials |
| NCT00166270 | MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids | completed | N/A | 70 | InSightecINDUSTRY | 1 | Jul 9, 2018 | clinicaltrials |
| NCT03550703 | Open Label Immunotherapy of Myoma(V3-myoma) | unknown | Phase 2 | 30 | Immunitor LLCINDUSTRY | 1 | Jul 6, 2018 | clinicaltrials |
| NCT02983539 | Detection of Circulating Tumor Cells in Patients With Sarcomas(CTCS) | unknown | — | 20 | AC Camargo Cancer CenterOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT00659360 | AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 2 | Jun 29, 2018 | clinicaltrials |
| NCT01502410 | Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 3 | Jun 26, 2018 | clinicaltrials |
| NCT00923351 | Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma | completed | Phase 1 / Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Jun 15, 2018 | clinicaltrials |
| NCT01328067 | Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids | withdrawn | N/A | 0 | InSightecINDUSTRY | 1 | Jun 15, 2018 | clinicaltrials |
| NCT00710346 | Establishment of Fibroid Tissue Bank | terminated | — | 43 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | Jun 1, 2018 | clinicaltrials |
| NCT01992718 | What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography | completed | Early Phase 1 | 49 | University of MichiganOTHER | 1 | May 31, 2018 | clinicaltrials |
| NCT00827645 | Uterine Artery Embolization and Pelvic Floor Symptoms | withdrawn | — | 0 | University of Texas Southwestern Medical CenterOTHER | 1 | May 22, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Jun 12, 2019source: clinicaltrials